Arax Advisory Partners’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Sell
777
-135
-15% -$2.88K ﹤0.01% 2210
2025
Q4
$21K Sell
912
-141
-13% -$3.55K ﹤0.01% 2083
2025
Q3
$29.7K Buy
1,053
+285
+37% +$7.83K ﹤0.01% 2088
2025
Q2
$21.3K Buy
768
+378
+97% +$11.2K ﹤0.01% 1638
2025
Q1
$12.6K Sell
390
-223
-36% -$7.23K ﹤0.01% 1493
2024
Q4
$19.5K Buy
613
+199
+48% +$6.14K ﹤0.01% 1220
2024
Q3
$11.9K Hold
414
﹤0.01% 1330
2024
Q2
$11.6K Buy
+414
New +$11K ﹤0.01% 1198

Other funds holding HSTM

Arax Advisory Partners's HSTM Position: Q1 2026 in Review

Arax Advisory Partners reduced its HealthStream (HSTM) stake by 15% in Q1 2026, selling an estimated $2.88K and leaving 777 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Arax Advisory Partners first reported a position in HSTM in Q2 2024 and has held it in 8 quarters since. The position peaked at $29.7K in Q3 2025. 197 funds tracked by Wall St. Rank hold HSTM as of Q1 2026.

  • Arax Advisory Partners held 777 shares of HealthStream worth $16.1K as of Q1 2026.
  • Arax Advisory Partners sold 135 HealthStream shares in Q1 2026, an estimated $2.88K.
  • HealthStream made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2210 holding.
  • Arax Advisory Partners first reported a position in HealthStream in Q2 2024 and has held it in 8 quarters since.
  • Arax Advisory Partners's HealthStream position peaked at $29.7K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held HealthStream as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.